3/4/2019 9:52 AM
The shares of Ascendis Pharma (NASDAQ:ASND) are up 66% at $114.96 this morning, after the company's pediatric growth-hormone drug, TransCon, succeeded in meeting the main goal of a late-stage trial. ...
9/22/2017 11:02 AM
Analysts are weighing in on e-commerce powerhouse eBay Inc (NASDAQ:EBAY), pharmaceutical company Ascendis Pharma (NASDAQ:ASND), and aerospace concern Boeing Co (NYSE:BA). Here's a quick roundup of ...